1.26
price down icon6.67%   -0.09
after-market Handel nachbörslich: 1.29 0.03 +2.38%
loading

Finanzdaten der Allarity Therapeutics Inc-Aktie (ALLR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
39.08%
2.518
4.133 3.036 7.317 12.31
Operating Income/Loss
39.08%
-2.518
-4.133 -3.036 -7.317 -12.31
Nonoperating Income/Loss
115.89%
-0.288
1.813 0.304 -0.136 0.346
Income/Loss From Continuing Operations Before Tax
20.95%
-2.806
-2.32 -2.732 -7.453 -11.97
Income Tax Expense/Benefit
-
- - - -0.377
Income/Loss From Continuing Operations After Tax
20.95%
-2.806
-2.32 -2.732 -7.453 -11.59
Net Income/Loss
20.95%
-2.806
-2.32 -2.732 -7.453 -11.59
Preferred Stock Dividends And Other Adjustments
-
- - - 0.562
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5.17%
14.74
15.54 11.15 0.9081 1.5758
Basic Earnings Per Share
26.67%
-0.19
-0.15 -0.25 9.68 -7.71
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - 0.562
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):